A large proportion of patients with ANCA-associated vasculitis discontinue treatment while in remission, but they appear to have fewer…
Articles by Iqra Mumal, MSc
The levels of two molecules in the blood — eosinophil cationic protein (ECP) and interleukin-5 (IL-5) — reflect eosinophil activation in…
Genentech‘s Rituxan (rituximab) is safe and effective to induce and maintain remission in patients with refractory or relapsing granulomatous…
A molecule known as chemokine receptor 8 (CCR8) can be seen at significantly high levels in people with active ANCA-associated…
Eosinophils, a type of immune cell, appear to contribute to the inflammatory process seen in patients with granulomatosis with…
A large proportion of patients with ANCA-associated vasculitis (AAV) who develop orbital mass, an eye complication, respond poorly to…
Patients with ANCA-associated vasculitis who have a kidney condition called glomerulonephritis have higher mortality rates than those without…
Patients with dermatomyositis — a condition marked by muscle weakness and a distinctive skin rash — can develop acute…
The ratio of neutrophils to lymphocytes — two types of immune cells — can be used to predict disease activity…
Roughly 1 in 10 patients with ANCA-associated vasculitis have another overlapping autoimmune disease, such as rheumatoid arthritis, lupus,…